Topic · 3 reports

Anti-Kickback Statute

RegulationWatch reporting on anti-kickback statute matters involving US pharmaceutical manufacturers, PBMs and healthcare companies, newest first.

  1. Anti-Kickback Statute

    Gilead paid its highest prescribers to speak. The settlement was $202 million.

    The company admitted paying doctors hundreds of thousands of dollars each. It still describes the programs as education.

  2. Anti-Kickback Statute

    Pfizer paid $2.3 billion over kickbacks, then asked to pay Vyndamax patients' copays. Speaker fees are the route the law still leaves open.

    The Anti-Kickback Statute bars paying doctors to prescribe. It still permits paying them to talk about the same drug, and patients never see who was paid.

  3. Anti-Kickback Statute

    Veloxis paid doctors and pharmacies to move a transplant drug, then hid the payments. The bill is over $46 million.

    The resolution includes the largest penalty ever for keeping payments out of the public Open Payments database. It was $1.55 million.